Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study
Table 1
Clinical characteristics among real-world initiators of GLP-1RA, SGLT2i and DPP-4i in Denmark, 2014–2017.